Clinical Trial Update: 3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009) [Phase 3]

View source ↗

Summary

A Phase 3 trial (P07009) comparing asenapine, olanzapine, and placebo for bipolar mania has completed. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Asenapine (asenapine)
• olanzapine (olanzapine)

Snippet

Sponsor: Organon and Co | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED